Literature DB >> 31584094

Effect of Seasonal Malaria Chemoprevention on Immune Markers of Exhaustion and Regulation.

Oumar Attaher1, Irfan Zaidi2, Jennifer L Kwan2, Djibrilla Issiaka1, Mamoudou B Samassekou1, Kadidia B Cisse1, Barou Coulibaly1, Sekouba Keita1, Sibiri Sissoko1, Tiangoua Traore1, Kalifa Diarra1, Bacary S Diarra1, Adama Dembele1, Moussa B Kanoute1, Almahamoudou Mahamar1, Amadou Barry1, Michal Fried2, Alassane Dicko1, Patrick E Duffy2.   

Abstract

BACKGROUND: Seasonal malaria chemoprevention (SMC) is a novel strategy to reduce malaria infections in children. Infection with Plasmodium falciparum results in immune dysfunction characterized by elevated expression of markers associated with exhaustion, such as PD1 and LAG3, and regulatory CD4+FOXP3+ T cells.
METHODS: In the current study, the impact of seasonal malaria chemoprevention on malaria-induced immune dysfunction, as measured by markers associated with exhaustion and regulatory T cells, was explored by flow cytometry.
RESULTS: Children that received seasonal malaria chemoprevention had fewer malaria episodes and showed significantly lower fold changes in CD4+PD1+ and CD4+PD1+LAG3+ compared to those that did not receive SMC. Seasonal malaria chemoprevention had no observable effect on fold changes in CD8 T cells expressing PD1 or CD160. However, children receiving SMC showed greater increases in CD4+FOXP3+ T regulatory cells compared to children not receiving SMC.
CONCLUSIONS: These results provide important insights into the dynamics of malaria-induced changes in the CD4 T-cell compartment of the immune system and suggest that the reduction of infections due to seasonal malaria chemoprevention may also prevent immune dysfunction. CLINICAL TRIALS REGISTRATION: NCT02504918. Published by Oxford University Press for the Infectious Diseases Society of America 2019.

Entities:  

Keywords:  T-cell exhaustion; T-cell regulation; immune dysfunction; seasonal malaria chemoprevention

Mesh:

Substances:

Year:  2020        PMID: 31584094      PMCID: PMC6910875          DOI: 10.1093/infdis/jiz415

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria.

Authors:  D Dodoo; F M Omer; J Todd; B D Akanmori; K A Koram; E M Riley
Journal:  J Infect Dis       Date:  2002-03-11       Impact factor: 5.226

2.  Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation.

Authors:  Haoting Hsu; Sarah Boudova; Godfrey Mvula; Titus H Divala; Randy G Mungwira; Christopher Harman; Miriam K Laufer; C David Pauza; Cristiana Cairo
Journal:  J Immunol       Date:  2016-07-29       Impact factor: 5.422

3.  An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection.

Authors:  Tuan M Tran; Shanping Li; Safiatou Doumbo; Didier Doumtabe; Chiung-Yu Huang; Seydou Dia; Aboudramane Bathily; Jules Sangala; Younoussou Kone; Abdrahamane Traore; Moussa Niangaly; Charles Dara; Kassoum Kayentao; Aissata Ongoiba; Ogobara K Doumbo; Boubacar Traore; Peter D Crompton
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

4.  Homeostatic regulation of T effector to Treg ratios in an area of seasonal malaria transmission.

Authors:  Olivia C Finney; Davis Nwakanma; David J Conway; Michael Walther; Eleanor M Riley
Journal:  Eur J Immunol       Date:  2009-05       Impact factor: 5.532

5.  Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.

Authors:  Badara Cissé; Cheikh Sokhna; Denis Boulanger; Jacqueline Milet; El Hadj Bâ; Keshena Richardson; Rachel Hallett; Colin Sutherland; Kirsten Simondon; François Simondon; Neal Alexander; Oumar Gaye; Geoffrey Targett; Jo Lines; Brian Greenwood; Jean-François Trape
Journal:  Lancet       Date:  2006-02-25       Impact factor: 79.321

6.  Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.

Authors:  Amadou T Konaté; Jean Baptiste Yaro; Amidou Z Ouédraogo; Amidou Diarra; Adama Gansané; Issiaka Soulama; David T Kangoyé; Youssouf Kaboré; Espérance Ouédraogo; Alphonse Ouédraogo; Alfred B Tiono; Issa N Ouédraogo; Daniel Chandramohan; Simon Cousens; Paul J Milligan; Sodiomon B Sirima; Brian Greenwood; Diadier A Diallo
Journal:  PLoS Med       Date:  2011-02-01       Impact factor: 11.069

7.  Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection.

Authors:  Noah S Butler; Jacqueline Moebius; Lecia L Pewe; Boubacar Traore; Ogobara K Doumbo; Lorraine T Tygrett; Thomas J Waldschmidt; Peter D Crompton; John T Harty
Journal:  Nat Immunol       Date:  2011-12-11       Impact factor: 25.606

8.  IFNγ/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children.

Authors:  Prasanna Jagannathan; Ijeoma Eccles-James; Katherine Bowen; Felistas Nankya; Ann Auma; Samuel Wamala; Charles Ebusu; Mary K Muhindo; Emmanuel Arinaitwe; Jessica Briggs; Bryan Greenhouse; Jordan W Tappero; Moses R Kamya; Grant Dorsey; Margaret E Feeney
Journal:  PLoS Pathog       Date:  2014-01-09       Impact factor: 6.823

9.  Transient Loss of Protection Afforded by a Live Attenuated Non-typhoidal Salmonella Vaccine in Mice Co-infected with Malaria.

Authors:  Jason P Mooney; Seung-Joo Lee; Kristen L Lokken; Minelva R Nanton; Sean-Paul Nuccio; Stephen J McSorley; Renée M Tsolis
Journal:  PLoS Negl Trop Dis       Date:  2015-09-14

10.  Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria.

Authors:  Annemieke Abel; Christiane Steeg; Francis Aminkiah; Otchere Addai-Mensah; Marylyn Addo; Nicola Gagliani; Christian Casar; Denis Dekugmen Yar; Ellis Owusu-Dabo; Thomas Jacobs; Maria Sophia Mackroth
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

View more
  2 in total

1.  Evolution of Malaria Incidence in Five Health Districts, in the Context of the Scaling Up of Seasonal Malaria Chemoprevention, 2016 to 2018, in Mali.

Authors:  Aissata Sacko; Issaka Sagara; Ibrahima Berthé; Modibo Diarra; Mady Cissoko; Souleymane S Diarra; Drissa Coulibaly; Moussa Sanogo; Alassane Dicko
Journal:  Int J Environ Res Public Health       Date:  2021-01-19       Impact factor: 3.390

Review 2.  Seasonal Malaria Chemoprevention Implementation: Effect on Malaria Incidence and Immunity in a Context of Expansion of P. falciparum Resistant Genotypes with Potential Reduction of the Effectiveness in Sub-Saharan Africa.

Authors:  Séni Nikiema; Issiaka Soulama; Salif Sombié; André-Marie Tchouatieu; Samuel Sindie Sermé; Noëlie Béré Henry; Nicolas Ouedraogo; Nathalie Ouaré; Raissa Ily; Oumarou Ouédraogo; Dramane Zongo; Florencia Wendkuuni Djigma; Alfred B Tiono; Sodiomon B Sirima; Jacques Simporé
Journal:  Infect Drug Resist       Date:  2022-08-13       Impact factor: 4.177

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.